BioMarin Pharmaceutical
BMRN
#1976
Rank
$10.46 B
Marketcap
$54.15
Share price
-0.86%
Change (1 day)
-11.95%
Change (1 year)

P/S ratio for BioMarin Pharmaceutical (BMRN)

P/S ratio as of April 2026 (TTM): 3.25

According to BioMarin Pharmaceutical's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.72. At the end of 2025 the company had a P/S ratio of 3.55.

P/S ratio history for BioMarin Pharmaceutical from 2001 to 2025

PS ratio at the end of each year

Year P/S ratio Change
20253.55-20.63%
20244.47-40.5%
20237.51-18.18%
20229.184.45%
20218.792.68%
20208.56-4.11%
20198.92-12.33%
201810.2-14.62%
201711.9-6.55%
201612.8-32.91%
201519.05.92%
201418.0-2.43%
201318.448.85%
201212.438.95%
20118.9012.36%
20107.9235.37%
20095.85-2.4%
20085.99-78.8%
200728.358.38%
200617.9-42.79%
200531.241.13%
200422.1-16.81%
200326.6-2.43%
200227.2-60.02%
200168.1

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Sanofi
SNY
2.08-35.86%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
3.60 10.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
3.25 0.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
1.67-48.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
7.16 120.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
5.41 66.62%๐Ÿ‡บ๐Ÿ‡ธ USA